Ronald Levy: Clinical Trials

5 trials sponsored by Ronald Levy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed. 3 Phase 1, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 13Completed 3
Phase 23Completed 3

Follow Ronald Levy: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
SD-101 and BMS-986178 in Treating Patients With Advanced or Metastatic Solid Malignancies
Anti-OX40 Antibody BMS 986178, TLR9 Agonist SD-101 - Advanced Malignant Solid Neoplasm, Extracranial Solid Neoplasm
Phase 1CompletedRonald Levy122019-03-132023-11-22
TLR9 Agonist SD-101, Anti-OX40 Antibody BMS 986178, and Radiation Therapy in Treating Patients With Low-Grade B-Cell Non-Hodgkin Lymphomas
Anti-OX40 Antibody BMS 986178, Laboratory Biomarker Analysis, Radiation Therapy - B-Cell Non-Hodgkin Lymphoma, Grade 1 Follicular Lymphoma
Phase 1CompletedRonald Levy142018-04-092024-12-11
Phase 1-2 of a CpG-Activated Whole Cell Vaccine Followed by Autologous Immunotransplant for MCL
CpG-MCL vaccine, PF-3512676, Vaccine-primed T-cells - Lymphoma, Mantle-Cell
Phase 2CompletedRonald Levy592009-08-012020-01-13
A Phase 2 Intratumoral Injection PF-3512676 Plus Local Radiation in Low-Grade B-Cell Lymphomas
PF-3512676, Local radiotherapy - Lymphoma, Non-Hodgkin, Lymphoma
Phase 2CompletedRonald Levy302009-01-012017-03-14
CPG 7909 + Local Radiotherapy in Recurrent Low-Grade Lymphomas
CPG 7909 - Non-Hodgkin Lymphoma, Mycosis Fungoides
Phase 1 / Phase 2CompletedRonald Levy302004-07-012014-08-01

Conditions studied

Lymphoma (2)  ·  Lymphoma, Mantle-Cell (2)  ·  Lymphoma, Non-Hodgkin (2)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (1)  ·  Lymphoma, B-Cell (1)  ·  Lymphoma, B-Cell, Marginal Zone (1)  ·  Lymphoma, Follicular (1)  ·  Mycoses (1)  ·  Mycosis Fungoides (1)  ·  Neoplasm Metastasis (1)

Interventions

ProMune (3)  ·  Cyclophosphamide (1)  ·  Filgrastim (1)  ·  Granulocyte Colony-Stimulating Factor (1)  ·  Radiation (1)  ·  Radiotherapy (1)  ·  Rituximab (1)  ·  Transplantation (1)

Countries

United States (5)

Top investigators

Saad A Khan (1)

Results publications

PMID 35135810, PMID 20697067, PMID 22045986, PMID 32558897, PMID 34780125

NIH funding

R35CA197353 (1)